Medicare Enrolled
Dr. Ahmad Fora, MD
Hematology & Oncology · Olympia, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fora from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fora?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fora
Dr. Ahmad Fora is a hematology & oncology specialist in Olympia, WA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Fora performed 5,090 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fora received a total of $11,308 from 76 pharmaceutical and/or device companies across 522 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fora is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 15% volume in WA
$11,308 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,090
Medicare services
Top 15% in WA for hematology & oncology
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,440 | $19 | $64 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
917 | $81 | $268 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
609 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
529 | $8 | $29 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
459 | $52 | $180 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
440 | $0 | $1 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
99 | $13 | $66 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
81 | $76 | $282 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $127 | $467 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
57 | $108 | $421 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
54 | $69 | $210 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
52 | $128 | $430 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $53 | $205 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
44 | $95 | $307 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
42 | $59 | $234 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
35 | $24 | $103 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
35 | $12 | $67 |
| New patient office visit, complex (60-74 min) | 34 | $171 | $667 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
34 | $1 | $4 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
15 | $53 | $208 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
3.0% high complexity
41.1% medium
56.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,308
Total received (2018-2024)
Avg $1,615/year across 7 years
Top 20% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
522
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,468
2023
$2,098
2022
$185
2021
$843
2020
$1,245
2019
$1,408
2018
$1,061
Payments by company (2024)
ABBVIE INC.
$375
AstraZeneca Pharmaceuticals LP
$366
Janssen Biotech, Inc.
$301
PFIZER INC.
$292
E.R. Squibb & Sons, L.L.C.
$259
Genentech USA, Inc.
$245
Merck Sharp & Dohme LLC
$245
Celgene Corporation
$223
Novartis Pharmaceuticals Corporation
$178
Incyte Corporation
$166
Astellas Pharma US Inc
$147
GlaxoSmithKline, LLC.
$130
Takeda Pharmaceuticals U.S.A., Inc.
$104
Bayer Healthcare Pharmaceuticals Inc.
$91
Exelixis Inc.
$84
BeiGene USA, Inc.
$79
ARRAY BIOPHARMA INC
$76
Acrotech Biopharma Inc.
$72
EMD Serono, Inc.
$71
Coherus Biosciences Inc.
$71
Daiichi Sankyo Inc.
$66
Tempus AI, Inc
$62
Regeneron Healthcare Solutions, Inc.
$59
TerSera Therapeutics LLC
$53
Apellis Pharmaceuticals, Inc.
$52
TAIHO ONCOLOGY, INC.
$49
Stemline Therapeutics Inc.
$48
Eisai Inc.
$43
Aveo Pharmaceuticals, Inc.
$42
Gilead Sciences, Inc.
$42
Agios Pharmaceuticals, Inc.
$35
Genmab U.S., Inc.
$34
Alnylam Pharmaceuticals Inc.
$31
SOBI, INC
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Karyopharm Therapeutics Inc.
$25
JAZZ PHARMACEUTICALS INC.
$24
Lilly USA, LLC
$23
Rigel Pharmaceuticals, Inc.
$22
Octapharma USA, Inc.
$22
ACCORD HEALTHCARE, INC.
$22
Pharmacosmos Therapeutics Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$15
Mirati Therapeutics, Inc.
$15
Ipsen Biopharmaceuticals, Inc
$14
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 23.3% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,203
PFIZER INC.
$650
AstraZeneca Pharmaceuticals LP
$641
Genentech USA, Inc.
$628
Janssen Biotech, Inc.
$561
Celgene Corporation
$531
Novartis Pharmaceuticals Corporation
$490
ABBVIE INC.
$375
Merck Sharp & Dohme LLC
$360
GlaxoSmithKline, LLC.
$326
Astellas Pharma US Inc
$314
Amgen Inc.
$312
Incyte Corporation
$298
Pharmacyclics LLC, An AbbVie Company
$269
Octapharma USA, Inc.
$250
Lilly USA, LLC
$242
Karyopharm Therapeutics Inc.
$220
GENZYME CORPORATION
$199
Eisai Inc.
$175
Merck Sharp & Dohme Corporation
$167
Daiichi Sankyo Inc.
$165
EMD Serono, Inc.
$146
Takeda Pharmaceuticals U.S.A., Inc.
$134
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
BeiGene USA, Inc.
$126
Bayer Healthcare Pharmaceuticals Inc.
$117
Exelixis Inc.
$116
Agios Pharmaceuticals, Inc.
$109
Regeneron Healthcare Solutions, Inc.
$104
Seagen Inc.
$85
Bayer HealthCare Pharmaceuticals Inc.
$79
Apellis Pharmaceuticals, Inc.
$77
ARRAY BIOPHARMA INC
$76
Acrotech Biopharma Inc.
$72
Coherus Biosciences Inc.
$71
TerSera Therapeutics LLC
$71
Gilead Sciences, Inc.
$70
Genmab U.S., Inc.
$68
Rigel Pharmaceuticals, Inc.
$66
SOBI, INC
$65
JAZZ PHARMACEUTICALS INC.
$64
Mirati Therapeutics, Inc.
$63
Tempus AI, Inc
$62
AbbVie, Inc.
$59
Kite Pharma, Inc.
$57
TAIHO ONCOLOGY, INC.
$49
Stemline Therapeutics Inc.
$48
Novocure Inc.
$46
Jazz Pharmaceuticals Inc.
$45
Aveo Pharmaceuticals, Inc.
$42
PUMA BIOTECHNOLOGY, INC.
$40
SANOFI-AVENTIS U.S. LLC
$40
Myovant Sciences Inc.
$33
Organon LLC
$33
Secura Bio, Inc.
$32
Alnylam Pharmaceuticals Inc.
$31
Seattle Genetics, Inc.
$31
Ipsen Biopharmaceuticals, Inc
$31
Spectrum Pharmaceuticals Inc.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Pharmacyclics LLC, an AbbVie Company
$24
Boston Scientific Corporation
$24
ACCORD HEALTHCARE, INC.
$22
Clovis Oncology, Inc.
$22
AVEO Pharmaceuticals, Inc.
$21
Acceleron Pharma, Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
Epizyme, Inc.,
$17
MorphoSys, US Inc.
$17
Sirtex Medical Inc
$17
ADC Therapeutics America, Inc.
$14
Tactile Systems Technology Inc
$13
Helsinn Therapeutics (U.S.), Inc.
$13
Puma Biotechnology, Inc.
$13
Kyowa Kirin, Inc.
$12
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · AUGTYRO · Abraxane · Alecensa · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · COSELA · CRESEMBA · CYRAMZA · Columvi · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Flexitouch Plus · GAZYVA · GENERAL - PAIN MANAGEMENT · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · IMLYGIC · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LARTRUVO · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXLUMO · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · REBLOZYL · RETACRIT · RETEVMO · ROLVEDON · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · SYLVANT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tazverik · Tecentriq · Udenyca · VENCLEXTA · VERZENIO · VIZIMPRO · VONJO · Vanflyta · Venclexta · Vyloy · XALKORI · XGEVA · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEPZELCA · ZIIHERA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
29
County median income
$93,985
Nearest hospital to ZIP centroid (approximate)
PROVIDENCE ST PETER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fora is a clinical cardiology specialist, with above-average Medicare volume (top 15% in WA), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fora experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Fora performed 1,440 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fora receive payments from pharmaceutical companies?
Yes. Dr. Fora received a total of $11,308 from 76 companies across 522 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fora's costs compare to other hematology & oncology specialists in Olympia?
Dr. Fora's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fora) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Olympia
Browse hematology & oncology specialists in Olympia ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in WA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in WA
Which WA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology